pharmaobservatory 0.1.3 → 0.1.4
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +4 -4
- data/README.md +101 -4
- data/docs/BiomarkerBqpAssertionsRow.md +1 -1
- data/docs/BiomarkerEvidenceRow.md +1 -1
- data/docs/BiomarkerLiteratureRow.md +1 -1
- data/docs/BiomarkerRelationsResponse.md +58 -0
- data/docs/BiomarkerRelationsRow.md +54 -0
- data/docs/BiomarkerSampleCoverageResponse.md +58 -0
- data/docs/BiomarkerSampleCoverageRow.md +36 -0
- data/docs/BiomarkerSamplePrevalenceResponse.md +58 -0
- data/docs/BiomarkerSamplePrevalenceRow.md +56 -0
- data/docs/BiomarkerValidationResponse.md +58 -0
- data/docs/BiomarkerValidationRow.md +70 -0
- data/docs/BiomarkersApi.md +320 -0
- data/docs/BiomarkersRow.md +2 -2
- data/docs/CellLinesRow.md +1 -1
- data/docs/CompaniesApi.md +410 -0
- data/docs/CompaniesRecord.md +1 -1
- data/docs/CompaniesRecordAttributes.md +18 -0
- data/docs/CompaniesRow.md +7 -3
- data/docs/CompanyAssetsResponse.md +58 -0
- data/docs/CompanyAssetsRow.md +42 -0
- data/docs/CompanyFundingEventsResponse.md +58 -0
- data/docs/CompanyFundingEventsRow.md +62 -0
- data/docs/CompanyFundingSummaryResponse.md +58 -0
- data/docs/CompanyFundingSummaryRow.md +46 -0
- data/docs/CompanyProgramsRow.md +2 -2
- data/docs/ConditionAdverseEventsResponse.md +58 -0
- data/docs/ConditionAdverseEventsRow.md +24 -0
- data/docs/ConditionBurdenResponse.md +58 -0
- data/docs/ConditionBurdenRow.md +32 -0
- data/docs/ConditionDeliveryResponse.md +58 -0
- data/docs/ConditionDeliveryRow.md +44 -0
- data/docs/ConditionDrugsResponse.md +58 -0
- data/docs/ConditionDrugsRow.md +26 -0
- data/docs/ConditionPrevalenceResponse.md +58 -0
- data/docs/ConditionPrevalenceRow.md +62 -0
- data/docs/ConditionPublicationsResponse.md +58 -0
- data/docs/ConditionPublicationsRow.md +32 -0
- data/docs/ConditionSitesResponse.md +58 -0
- data/docs/ConditionSitesRow.md +28 -0
- data/docs/ConditionTrialsResponse.md +58 -0
- data/docs/ConditionTrialsRow.md +58 -0
- data/docs/ConditionsApi.md +953 -0
- data/docs/ConditionsRecord.md +38 -0
- data/docs/ConditionsRecordAttributes.md +20 -0
- data/docs/ConditionsResponse.md +58 -0
- data/docs/ConditionsRow.md +32 -0
- data/docs/DrugPatentCliffRow.md +1 -1
- data/docs/InstitutionalHoldingsRow.md +3 -1
- data/docs/LegalEntitiesApi.md +160 -0
- data/docs/LegalEntitiesRow.md +1 -1
- data/docs/OwnershipPositionsResponse.md +58 -0
- data/docs/OwnershipPositionsRow.md +100 -0
- data/docs/PdufaDatesRow.md +2 -2
- data/docs/SiteCroTrialsRow.md +1 -1
- data/docs/SiteTrialConditionsRow.md +1 -1
- data/docs/SiteTrialDrugsRow.md +1 -1
- data/docs/SiteTrialsRow.md +1 -1
- data/docs/SponsorRecruitmentByPhaseRow.md +2 -2
- data/docs/SponsorRecruitmentDurationRow.md +1 -1
- data/docs/SponsorTrialsRow.md +2 -2
- data/docs/TrialAdverseEventsResponse.md +58 -0
- data/docs/TrialAdverseEventsRow.md +28 -0
- data/docs/TrialChangesResponse.md +58 -0
- data/docs/TrialChangesRow.md +36 -0
- data/docs/TrialDeliveryResponse.md +58 -0
- data/docs/TrialDeliveryRow.md +64 -0
- data/docs/TrialDemographicsResponse.md +58 -0
- data/docs/TrialDemographicsRow.md +32 -0
- data/docs/TrialDrugsResponse.md +58 -0
- data/docs/TrialDrugsRow.md +30 -0
- data/docs/TrialEnrollmentHistoryResponse.md +58 -0
- data/docs/TrialEnrollmentHistoryRow.md +36 -0
- data/docs/TrialEnrollmentRateResponse.md +58 -0
- data/docs/TrialEnrollmentRateRow.md +58 -0
- data/docs/TrialExtractedEndpointsResponse.md +58 -0
- data/docs/TrialExtractedEndpointsRow.md +40 -0
- data/docs/TrialOutcomeMeasuresResponse.md +58 -0
- data/docs/TrialOutcomeMeasuresRow.md +28 -0
- data/docs/TrialSitesResponse.md +58 -0
- data/docs/TrialSitesRow.md +46 -0
- data/docs/TrialsApi.md +1033 -0
- data/docs/TrialsRecord.md +38 -0
- data/docs/TrialsRecordAttributes.md +24 -0
- data/docs/TrialsResponse.md +58 -0
- data/docs/TrialsRow.md +116 -0
- data/lib/pharmaobservatory/api/biomarkers_api.rb +336 -0
- data/lib/pharmaobservatory/api/companies_api.rb +455 -0
- data/lib/pharmaobservatory/api/conditions_api.rb +1001 -0
- data/lib/pharmaobservatory/api/legal_entities_api.rb +168 -0
- data/lib/pharmaobservatory/api/trials_api.rb +1085 -0
- data/lib/pharmaobservatory/models/biomarker_bqp_assertions_row.rb +1 -1
- data/lib/pharmaobservatory/models/biomarker_evidence_row.rb +1 -1
- data/lib/pharmaobservatory/models/biomarker_literature_row.rb +1 -1
- data/lib/pharmaobservatory/models/biomarker_relations_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_relations_row.rb +421 -0
- data/lib/pharmaobservatory/models/biomarker_sample_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_sample_coverage_row.rb +322 -0
- data/lib/pharmaobservatory/models/biomarker_sample_prevalence_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_sample_prevalence_row.rb +436 -0
- data/lib/pharmaobservatory/models/biomarker_validation_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_validation_row.rb +509 -0
- data/lib/pharmaobservatory/models/biomarkers_row.rb +2 -2
- data/lib/pharmaobservatory/models/cell_lines_row.rb +1 -1
- data/lib/pharmaobservatory/models/companies_record.rb +1 -1
- data/lib/pharmaobservatory/models/companies_record_attributes.rb +220 -0
- data/lib/pharmaobservatory/models/companies_row.rb +29 -7
- data/lib/pharmaobservatory/models/company_assets_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_assets_row.rb +355 -0
- data/lib/pharmaobservatory/models/company_funding_events_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_funding_events_row.rb +465 -0
- data/lib/pharmaobservatory/models/company_funding_summary_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_funding_summary_row.rb +377 -0
- data/lib/pharmaobservatory/models/company_programs_row.rb +2 -2
- data/lib/pharmaobservatory/models/condition_adverse_events_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_adverse_events_row.rb +256 -0
- data/lib/pharmaobservatory/models/condition_burden_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_burden_row.rb +300 -0
- data/lib/pharmaobservatory/models/condition_delivery_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_delivery_row.rb +366 -0
- data/lib/pharmaobservatory/models/condition_drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_drugs_row.rb +267 -0
- data/lib/pharmaobservatory/models/condition_prevalence_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_prevalence_row.rb +465 -0
- data/lib/pharmaobservatory/models/condition_publications_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_publications_row.rb +300 -0
- data/lib/pharmaobservatory/models/condition_sites_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_sites_row.rb +278 -0
- data/lib/pharmaobservatory/models/condition_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_trials_row.rb +443 -0
- data/lib/pharmaobservatory/models/conditions_record.rb +385 -0
- data/lib/pharmaobservatory/models/conditions_record_attributes.rb +229 -0
- data/lib/pharmaobservatory/models/conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/conditions_row.rb +304 -0
- data/lib/pharmaobservatory/models/drug_patent_cliff_row.rb +1 -1
- data/lib/pharmaobservatory/models/institutional_holdings_row.rb +13 -2
- data/lib/pharmaobservatory/models/legal_entities_row.rb +1 -1
- data/lib/pharmaobservatory/models/ownership_positions_response.rb +478 -0
- data/lib/pharmaobservatory/models/ownership_positions_row.rb +674 -0
- data/lib/pharmaobservatory/models/pdufa_dates_row.rb +2 -2
- data/lib/pharmaobservatory/models/site_cro_trials_row.rb +1 -1
- data/lib/pharmaobservatory/models/site_trial_conditions_row.rb +1 -1
- data/lib/pharmaobservatory/models/site_trial_drugs_row.rb +1 -1
- data/lib/pharmaobservatory/models/site_trials_row.rb +1 -1
- data/lib/pharmaobservatory/models/sponsor_recruitment_by_phase_row.rb +2 -2
- data/lib/pharmaobservatory/models/sponsor_recruitment_duration_row.rb +1 -1
- data/lib/pharmaobservatory/models/sponsor_trials_row.rb +2 -2
- data/lib/pharmaobservatory/models/trial_adverse_events_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_adverse_events_row.rb +278 -0
- data/lib/pharmaobservatory/models/trial_changes_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_changes_row.rb +328 -0
- data/lib/pharmaobservatory/models/trial_delivery_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_delivery_row.rb +476 -0
- data/lib/pharmaobservatory/models/trial_demographics_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_demographics_row.rb +300 -0
- data/lib/pharmaobservatory/models/trial_drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_drugs_row.rb +291 -0
- data/lib/pharmaobservatory/models/trial_enrollment_history_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_enrollment_history_row.rb +322 -0
- data/lib/pharmaobservatory/models/trial_enrollment_rate_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_enrollment_rate_row.rb +443 -0
- data/lib/pharmaobservatory/models/trial_extracted_endpoints_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_extracted_endpoints_row.rb +346 -0
- data/lib/pharmaobservatory/models/trial_outcome_measures_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_outcome_measures_row.rb +278 -0
- data/lib/pharmaobservatory/models/trial_sites_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_sites_row.rb +377 -0
- data/lib/pharmaobservatory/models/trials_record.rb +385 -0
- data/lib/pharmaobservatory/models/trials_record_attributes.rb +247 -0
- data/lib/pharmaobservatory/models/trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/trials_row.rb +784 -0
- data/lib/pharmaobservatory/version.rb +1 -1
- data/lib/pharmaobservatory.rb +63 -0
- metadata +127 -1
data/lib/pharmaobservatory.rb
CHANGED
|
@@ -32,6 +32,14 @@ require 'pharmaobservatory/models/biomarker_literature_response'
|
|
|
32
32
|
require 'pharmaobservatory/models/biomarker_literature_row'
|
|
33
33
|
require 'pharmaobservatory/models/biomarker_publishing_companies_response'
|
|
34
34
|
require 'pharmaobservatory/models/biomarker_publishing_companies_row'
|
|
35
|
+
require 'pharmaobservatory/models/biomarker_relations_response'
|
|
36
|
+
require 'pharmaobservatory/models/biomarker_relations_row'
|
|
37
|
+
require 'pharmaobservatory/models/biomarker_sample_coverage_response'
|
|
38
|
+
require 'pharmaobservatory/models/biomarker_sample_coverage_row'
|
|
39
|
+
require 'pharmaobservatory/models/biomarker_sample_prevalence_response'
|
|
40
|
+
require 'pharmaobservatory/models/biomarker_sample_prevalence_row'
|
|
41
|
+
require 'pharmaobservatory/models/biomarker_validation_response'
|
|
42
|
+
require 'pharmaobservatory/models/biomarker_validation_row'
|
|
35
43
|
require 'pharmaobservatory/models/biomarker_variant_mentions_response'
|
|
36
44
|
require 'pharmaobservatory/models/biomarker_variant_mentions_row'
|
|
37
45
|
require 'pharmaobservatory/models/biomarkers_record'
|
|
@@ -41,14 +49,41 @@ require 'pharmaobservatory/models/cell_lines_record'
|
|
|
41
49
|
require 'pharmaobservatory/models/cell_lines_response'
|
|
42
50
|
require 'pharmaobservatory/models/cell_lines_row'
|
|
43
51
|
require 'pharmaobservatory/models/companies_record'
|
|
52
|
+
require 'pharmaobservatory/models/companies_record_attributes'
|
|
44
53
|
require 'pharmaobservatory/models/companies_response'
|
|
45
54
|
require 'pharmaobservatory/models/companies_row'
|
|
55
|
+
require 'pharmaobservatory/models/company_assets_response'
|
|
56
|
+
require 'pharmaobservatory/models/company_assets_row'
|
|
57
|
+
require 'pharmaobservatory/models/company_funding_events_response'
|
|
58
|
+
require 'pharmaobservatory/models/company_funding_events_row'
|
|
59
|
+
require 'pharmaobservatory/models/company_funding_summary_response'
|
|
60
|
+
require 'pharmaobservatory/models/company_funding_summary_row'
|
|
46
61
|
require 'pharmaobservatory/models/company_members_response'
|
|
47
62
|
require 'pharmaobservatory/models/company_members_row'
|
|
48
63
|
require 'pharmaobservatory/models/company_programs_response'
|
|
49
64
|
require 'pharmaobservatory/models/company_programs_row'
|
|
50
65
|
require 'pharmaobservatory/models/company_targets_response'
|
|
51
66
|
require 'pharmaobservatory/models/company_targets_row'
|
|
67
|
+
require 'pharmaobservatory/models/condition_adverse_events_response'
|
|
68
|
+
require 'pharmaobservatory/models/condition_adverse_events_row'
|
|
69
|
+
require 'pharmaobservatory/models/condition_burden_response'
|
|
70
|
+
require 'pharmaobservatory/models/condition_burden_row'
|
|
71
|
+
require 'pharmaobservatory/models/condition_delivery_response'
|
|
72
|
+
require 'pharmaobservatory/models/condition_delivery_row'
|
|
73
|
+
require 'pharmaobservatory/models/condition_drugs_response'
|
|
74
|
+
require 'pharmaobservatory/models/condition_drugs_row'
|
|
75
|
+
require 'pharmaobservatory/models/condition_prevalence_response'
|
|
76
|
+
require 'pharmaobservatory/models/condition_prevalence_row'
|
|
77
|
+
require 'pharmaobservatory/models/condition_publications_response'
|
|
78
|
+
require 'pharmaobservatory/models/condition_publications_row'
|
|
79
|
+
require 'pharmaobservatory/models/condition_sites_response'
|
|
80
|
+
require 'pharmaobservatory/models/condition_sites_row'
|
|
81
|
+
require 'pharmaobservatory/models/condition_trials_response'
|
|
82
|
+
require 'pharmaobservatory/models/condition_trials_row'
|
|
83
|
+
require 'pharmaobservatory/models/conditions_record'
|
|
84
|
+
require 'pharmaobservatory/models/conditions_record_attributes'
|
|
85
|
+
require 'pharmaobservatory/models/conditions_response'
|
|
86
|
+
require 'pharmaobservatory/models/conditions_row'
|
|
52
87
|
require 'pharmaobservatory/models/dataset_attribution'
|
|
53
88
|
require 'pharmaobservatory/models/dataset_build_state'
|
|
54
89
|
require 'pharmaobservatory/models/dataset_column'
|
|
@@ -63,6 +98,8 @@ require 'pharmaobservatory/models/legal_entities_record'
|
|
|
63
98
|
require 'pharmaobservatory/models/legal_entities_record_attributes'
|
|
64
99
|
require 'pharmaobservatory/models/legal_entities_response'
|
|
65
100
|
require 'pharmaobservatory/models/legal_entities_row'
|
|
101
|
+
require 'pharmaobservatory/models/ownership_positions_response'
|
|
102
|
+
require 'pharmaobservatory/models/ownership_positions_row'
|
|
66
103
|
require 'pharmaobservatory/models/pdufa_dates_response'
|
|
67
104
|
require 'pharmaobservatory/models/pdufa_dates_row'
|
|
68
105
|
require 'pharmaobservatory/models/query_error'
|
|
@@ -96,16 +133,42 @@ require 'pharmaobservatory/models/sponsor_trial_start_forecast_response'
|
|
|
96
133
|
require 'pharmaobservatory/models/sponsor_trial_start_forecast_row'
|
|
97
134
|
require 'pharmaobservatory/models/sponsor_trials_response'
|
|
98
135
|
require 'pharmaobservatory/models/sponsor_trials_row'
|
|
136
|
+
require 'pharmaobservatory/models/trial_adverse_events_response'
|
|
137
|
+
require 'pharmaobservatory/models/trial_adverse_events_row'
|
|
138
|
+
require 'pharmaobservatory/models/trial_changes_response'
|
|
139
|
+
require 'pharmaobservatory/models/trial_changes_row'
|
|
140
|
+
require 'pharmaobservatory/models/trial_delivery_response'
|
|
141
|
+
require 'pharmaobservatory/models/trial_delivery_row'
|
|
142
|
+
require 'pharmaobservatory/models/trial_demographics_response'
|
|
143
|
+
require 'pharmaobservatory/models/trial_demographics_row'
|
|
144
|
+
require 'pharmaobservatory/models/trial_drugs_response'
|
|
145
|
+
require 'pharmaobservatory/models/trial_drugs_row'
|
|
146
|
+
require 'pharmaobservatory/models/trial_enrollment_history_response'
|
|
147
|
+
require 'pharmaobservatory/models/trial_enrollment_history_row'
|
|
148
|
+
require 'pharmaobservatory/models/trial_enrollment_rate_response'
|
|
149
|
+
require 'pharmaobservatory/models/trial_enrollment_rate_row'
|
|
150
|
+
require 'pharmaobservatory/models/trial_extracted_endpoints_response'
|
|
151
|
+
require 'pharmaobservatory/models/trial_extracted_endpoints_row'
|
|
152
|
+
require 'pharmaobservatory/models/trial_outcome_measures_response'
|
|
153
|
+
require 'pharmaobservatory/models/trial_outcome_measures_row'
|
|
154
|
+
require 'pharmaobservatory/models/trial_sites_response'
|
|
155
|
+
require 'pharmaobservatory/models/trial_sites_row'
|
|
156
|
+
require 'pharmaobservatory/models/trials_record'
|
|
157
|
+
require 'pharmaobservatory/models/trials_record_attributes'
|
|
158
|
+
require 'pharmaobservatory/models/trials_response'
|
|
159
|
+
require 'pharmaobservatory/models/trials_row'
|
|
99
160
|
|
|
100
161
|
# APIs
|
|
101
162
|
require 'pharmaobservatory/api/api_v1_base_api'
|
|
102
163
|
require 'pharmaobservatory/api/biomarkers_api'
|
|
103
164
|
require 'pharmaobservatory/api/cell_lines_api'
|
|
104
165
|
require 'pharmaobservatory/api/companies_api'
|
|
166
|
+
require 'pharmaobservatory/api/conditions_api'
|
|
105
167
|
require 'pharmaobservatory/api/datasets_api'
|
|
106
168
|
require 'pharmaobservatory/api/legal_entities_api'
|
|
107
169
|
require 'pharmaobservatory/api/query_api'
|
|
108
170
|
require 'pharmaobservatory/api/sites_api'
|
|
171
|
+
require 'pharmaobservatory/api/trials_api'
|
|
109
172
|
|
|
110
173
|
module PharmaObservatory
|
|
111
174
|
class << self
|
metadata
CHANGED
|
@@ -1,7 +1,7 @@
|
|
|
1
1
|
--- !ruby/object:Gem::Specification
|
|
2
2
|
name: pharmaobservatory
|
|
3
3
|
version: !ruby/object:Gem::Version
|
|
4
|
-
version: 0.1.
|
|
4
|
+
version: 0.1.4
|
|
5
5
|
platform: ruby
|
|
6
6
|
authors:
|
|
7
7
|
- Scientist.com
|
|
@@ -103,6 +103,14 @@ files:
|
|
|
103
103
|
- docs/BiomarkerLiteratureRow.md
|
|
104
104
|
- docs/BiomarkerPublishingCompaniesResponse.md
|
|
105
105
|
- docs/BiomarkerPublishingCompaniesRow.md
|
|
106
|
+
- docs/BiomarkerRelationsResponse.md
|
|
107
|
+
- docs/BiomarkerRelationsRow.md
|
|
108
|
+
- docs/BiomarkerSampleCoverageResponse.md
|
|
109
|
+
- docs/BiomarkerSampleCoverageRow.md
|
|
110
|
+
- docs/BiomarkerSamplePrevalenceResponse.md
|
|
111
|
+
- docs/BiomarkerSamplePrevalenceRow.md
|
|
112
|
+
- docs/BiomarkerValidationResponse.md
|
|
113
|
+
- docs/BiomarkerValidationRow.md
|
|
106
114
|
- docs/BiomarkerVariantMentionsResponse.md
|
|
107
115
|
- docs/BiomarkerVariantMentionsRow.md
|
|
108
116
|
- docs/BiomarkersApi.md
|
|
@@ -115,14 +123,42 @@ files:
|
|
|
115
123
|
- docs/CellLinesRow.md
|
|
116
124
|
- docs/CompaniesApi.md
|
|
117
125
|
- docs/CompaniesRecord.md
|
|
126
|
+
- docs/CompaniesRecordAttributes.md
|
|
118
127
|
- docs/CompaniesResponse.md
|
|
119
128
|
- docs/CompaniesRow.md
|
|
129
|
+
- docs/CompanyAssetsResponse.md
|
|
130
|
+
- docs/CompanyAssetsRow.md
|
|
131
|
+
- docs/CompanyFundingEventsResponse.md
|
|
132
|
+
- docs/CompanyFundingEventsRow.md
|
|
133
|
+
- docs/CompanyFundingSummaryResponse.md
|
|
134
|
+
- docs/CompanyFundingSummaryRow.md
|
|
120
135
|
- docs/CompanyMembersResponse.md
|
|
121
136
|
- docs/CompanyMembersRow.md
|
|
122
137
|
- docs/CompanyProgramsResponse.md
|
|
123
138
|
- docs/CompanyProgramsRow.md
|
|
124
139
|
- docs/CompanyTargetsResponse.md
|
|
125
140
|
- docs/CompanyTargetsRow.md
|
|
141
|
+
- docs/ConditionAdverseEventsResponse.md
|
|
142
|
+
- docs/ConditionAdverseEventsRow.md
|
|
143
|
+
- docs/ConditionBurdenResponse.md
|
|
144
|
+
- docs/ConditionBurdenRow.md
|
|
145
|
+
- docs/ConditionDeliveryResponse.md
|
|
146
|
+
- docs/ConditionDeliveryRow.md
|
|
147
|
+
- docs/ConditionDrugsResponse.md
|
|
148
|
+
- docs/ConditionDrugsRow.md
|
|
149
|
+
- docs/ConditionPrevalenceResponse.md
|
|
150
|
+
- docs/ConditionPrevalenceRow.md
|
|
151
|
+
- docs/ConditionPublicationsResponse.md
|
|
152
|
+
- docs/ConditionPublicationsRow.md
|
|
153
|
+
- docs/ConditionSitesResponse.md
|
|
154
|
+
- docs/ConditionSitesRow.md
|
|
155
|
+
- docs/ConditionTrialsResponse.md
|
|
156
|
+
- docs/ConditionTrialsRow.md
|
|
157
|
+
- docs/ConditionsApi.md
|
|
158
|
+
- docs/ConditionsRecord.md
|
|
159
|
+
- docs/ConditionsRecordAttributes.md
|
|
160
|
+
- docs/ConditionsResponse.md
|
|
161
|
+
- docs/ConditionsRow.md
|
|
126
162
|
- docs/DatasetAttribution.md
|
|
127
163
|
- docs/DatasetBuildState.md
|
|
128
164
|
- docs/DatasetColumn.md
|
|
@@ -139,6 +175,8 @@ files:
|
|
|
139
175
|
- docs/LegalEntitiesRecordAttributes.md
|
|
140
176
|
- docs/LegalEntitiesResponse.md
|
|
141
177
|
- docs/LegalEntitiesRow.md
|
|
178
|
+
- docs/OwnershipPositionsResponse.md
|
|
179
|
+
- docs/OwnershipPositionsRow.md
|
|
142
180
|
- docs/PdufaDatesResponse.md
|
|
143
181
|
- docs/PdufaDatesRow.md
|
|
144
182
|
- docs/QueryApi.md
|
|
@@ -174,15 +212,42 @@ files:
|
|
|
174
212
|
- docs/SponsorTrialStartForecastRow.md
|
|
175
213
|
- docs/SponsorTrialsResponse.md
|
|
176
214
|
- docs/SponsorTrialsRow.md
|
|
215
|
+
- docs/TrialAdverseEventsResponse.md
|
|
216
|
+
- docs/TrialAdverseEventsRow.md
|
|
217
|
+
- docs/TrialChangesResponse.md
|
|
218
|
+
- docs/TrialChangesRow.md
|
|
219
|
+
- docs/TrialDeliveryResponse.md
|
|
220
|
+
- docs/TrialDeliveryRow.md
|
|
221
|
+
- docs/TrialDemographicsResponse.md
|
|
222
|
+
- docs/TrialDemographicsRow.md
|
|
223
|
+
- docs/TrialDrugsResponse.md
|
|
224
|
+
- docs/TrialDrugsRow.md
|
|
225
|
+
- docs/TrialEnrollmentHistoryResponse.md
|
|
226
|
+
- docs/TrialEnrollmentHistoryRow.md
|
|
227
|
+
- docs/TrialEnrollmentRateResponse.md
|
|
228
|
+
- docs/TrialEnrollmentRateRow.md
|
|
229
|
+
- docs/TrialExtractedEndpointsResponse.md
|
|
230
|
+
- docs/TrialExtractedEndpointsRow.md
|
|
231
|
+
- docs/TrialOutcomeMeasuresResponse.md
|
|
232
|
+
- docs/TrialOutcomeMeasuresRow.md
|
|
233
|
+
- docs/TrialSitesResponse.md
|
|
234
|
+
- docs/TrialSitesRow.md
|
|
235
|
+
- docs/TrialsApi.md
|
|
236
|
+
- docs/TrialsRecord.md
|
|
237
|
+
- docs/TrialsRecordAttributes.md
|
|
238
|
+
- docs/TrialsResponse.md
|
|
239
|
+
- docs/TrialsRow.md
|
|
177
240
|
- lib/pharmaobservatory.rb
|
|
178
241
|
- lib/pharmaobservatory/api/api_v1_base_api.rb
|
|
179
242
|
- lib/pharmaobservatory/api/biomarkers_api.rb
|
|
180
243
|
- lib/pharmaobservatory/api/cell_lines_api.rb
|
|
181
244
|
- lib/pharmaobservatory/api/companies_api.rb
|
|
245
|
+
- lib/pharmaobservatory/api/conditions_api.rb
|
|
182
246
|
- lib/pharmaobservatory/api/datasets_api.rb
|
|
183
247
|
- lib/pharmaobservatory/api/legal_entities_api.rb
|
|
184
248
|
- lib/pharmaobservatory/api/query_api.rb
|
|
185
249
|
- lib/pharmaobservatory/api/sites_api.rb
|
|
250
|
+
- lib/pharmaobservatory/api/trials_api.rb
|
|
186
251
|
- lib/pharmaobservatory/api_client.rb
|
|
187
252
|
- lib/pharmaobservatory/api_error.rb
|
|
188
253
|
- lib/pharmaobservatory/configuration.rb
|
|
@@ -201,6 +266,14 @@ files:
|
|
|
201
266
|
- lib/pharmaobservatory/models/biomarker_literature_row.rb
|
|
202
267
|
- lib/pharmaobservatory/models/biomarker_publishing_companies_response.rb
|
|
203
268
|
- lib/pharmaobservatory/models/biomarker_publishing_companies_row.rb
|
|
269
|
+
- lib/pharmaobservatory/models/biomarker_relations_response.rb
|
|
270
|
+
- lib/pharmaobservatory/models/biomarker_relations_row.rb
|
|
271
|
+
- lib/pharmaobservatory/models/biomarker_sample_coverage_response.rb
|
|
272
|
+
- lib/pharmaobservatory/models/biomarker_sample_coverage_row.rb
|
|
273
|
+
- lib/pharmaobservatory/models/biomarker_sample_prevalence_response.rb
|
|
274
|
+
- lib/pharmaobservatory/models/biomarker_sample_prevalence_row.rb
|
|
275
|
+
- lib/pharmaobservatory/models/biomarker_validation_response.rb
|
|
276
|
+
- lib/pharmaobservatory/models/biomarker_validation_row.rb
|
|
204
277
|
- lib/pharmaobservatory/models/biomarker_variant_mentions_response.rb
|
|
205
278
|
- lib/pharmaobservatory/models/biomarker_variant_mentions_row.rb
|
|
206
279
|
- lib/pharmaobservatory/models/biomarkers_record.rb
|
|
@@ -210,14 +283,41 @@ files:
|
|
|
210
283
|
- lib/pharmaobservatory/models/cell_lines_response.rb
|
|
211
284
|
- lib/pharmaobservatory/models/cell_lines_row.rb
|
|
212
285
|
- lib/pharmaobservatory/models/companies_record.rb
|
|
286
|
+
- lib/pharmaobservatory/models/companies_record_attributes.rb
|
|
213
287
|
- lib/pharmaobservatory/models/companies_response.rb
|
|
214
288
|
- lib/pharmaobservatory/models/companies_row.rb
|
|
289
|
+
- lib/pharmaobservatory/models/company_assets_response.rb
|
|
290
|
+
- lib/pharmaobservatory/models/company_assets_row.rb
|
|
291
|
+
- lib/pharmaobservatory/models/company_funding_events_response.rb
|
|
292
|
+
- lib/pharmaobservatory/models/company_funding_events_row.rb
|
|
293
|
+
- lib/pharmaobservatory/models/company_funding_summary_response.rb
|
|
294
|
+
- lib/pharmaobservatory/models/company_funding_summary_row.rb
|
|
215
295
|
- lib/pharmaobservatory/models/company_members_response.rb
|
|
216
296
|
- lib/pharmaobservatory/models/company_members_row.rb
|
|
217
297
|
- lib/pharmaobservatory/models/company_programs_response.rb
|
|
218
298
|
- lib/pharmaobservatory/models/company_programs_row.rb
|
|
219
299
|
- lib/pharmaobservatory/models/company_targets_response.rb
|
|
220
300
|
- lib/pharmaobservatory/models/company_targets_row.rb
|
|
301
|
+
- lib/pharmaobservatory/models/condition_adverse_events_response.rb
|
|
302
|
+
- lib/pharmaobservatory/models/condition_adverse_events_row.rb
|
|
303
|
+
- lib/pharmaobservatory/models/condition_burden_response.rb
|
|
304
|
+
- lib/pharmaobservatory/models/condition_burden_row.rb
|
|
305
|
+
- lib/pharmaobservatory/models/condition_delivery_response.rb
|
|
306
|
+
- lib/pharmaobservatory/models/condition_delivery_row.rb
|
|
307
|
+
- lib/pharmaobservatory/models/condition_drugs_response.rb
|
|
308
|
+
- lib/pharmaobservatory/models/condition_drugs_row.rb
|
|
309
|
+
- lib/pharmaobservatory/models/condition_prevalence_response.rb
|
|
310
|
+
- lib/pharmaobservatory/models/condition_prevalence_row.rb
|
|
311
|
+
- lib/pharmaobservatory/models/condition_publications_response.rb
|
|
312
|
+
- lib/pharmaobservatory/models/condition_publications_row.rb
|
|
313
|
+
- lib/pharmaobservatory/models/condition_sites_response.rb
|
|
314
|
+
- lib/pharmaobservatory/models/condition_sites_row.rb
|
|
315
|
+
- lib/pharmaobservatory/models/condition_trials_response.rb
|
|
316
|
+
- lib/pharmaobservatory/models/condition_trials_row.rb
|
|
317
|
+
- lib/pharmaobservatory/models/conditions_record.rb
|
|
318
|
+
- lib/pharmaobservatory/models/conditions_record_attributes.rb
|
|
319
|
+
- lib/pharmaobservatory/models/conditions_response.rb
|
|
320
|
+
- lib/pharmaobservatory/models/conditions_row.rb
|
|
221
321
|
- lib/pharmaobservatory/models/dataset_attribution.rb
|
|
222
322
|
- lib/pharmaobservatory/models/dataset_build_state.rb
|
|
223
323
|
- lib/pharmaobservatory/models/dataset_column.rb
|
|
@@ -232,6 +332,8 @@ files:
|
|
|
232
332
|
- lib/pharmaobservatory/models/legal_entities_record_attributes.rb
|
|
233
333
|
- lib/pharmaobservatory/models/legal_entities_response.rb
|
|
234
334
|
- lib/pharmaobservatory/models/legal_entities_row.rb
|
|
335
|
+
- lib/pharmaobservatory/models/ownership_positions_response.rb
|
|
336
|
+
- lib/pharmaobservatory/models/ownership_positions_row.rb
|
|
235
337
|
- lib/pharmaobservatory/models/pdufa_dates_response.rb
|
|
236
338
|
- lib/pharmaobservatory/models/pdufa_dates_row.rb
|
|
237
339
|
- lib/pharmaobservatory/models/query_error.rb
|
|
@@ -265,6 +367,30 @@ files:
|
|
|
265
367
|
- lib/pharmaobservatory/models/sponsor_trial_start_forecast_row.rb
|
|
266
368
|
- lib/pharmaobservatory/models/sponsor_trials_response.rb
|
|
267
369
|
- lib/pharmaobservatory/models/sponsor_trials_row.rb
|
|
370
|
+
- lib/pharmaobservatory/models/trial_adverse_events_response.rb
|
|
371
|
+
- lib/pharmaobservatory/models/trial_adverse_events_row.rb
|
|
372
|
+
- lib/pharmaobservatory/models/trial_changes_response.rb
|
|
373
|
+
- lib/pharmaobservatory/models/trial_changes_row.rb
|
|
374
|
+
- lib/pharmaobservatory/models/trial_delivery_response.rb
|
|
375
|
+
- lib/pharmaobservatory/models/trial_delivery_row.rb
|
|
376
|
+
- lib/pharmaobservatory/models/trial_demographics_response.rb
|
|
377
|
+
- lib/pharmaobservatory/models/trial_demographics_row.rb
|
|
378
|
+
- lib/pharmaobservatory/models/trial_drugs_response.rb
|
|
379
|
+
- lib/pharmaobservatory/models/trial_drugs_row.rb
|
|
380
|
+
- lib/pharmaobservatory/models/trial_enrollment_history_response.rb
|
|
381
|
+
- lib/pharmaobservatory/models/trial_enrollment_history_row.rb
|
|
382
|
+
- lib/pharmaobservatory/models/trial_enrollment_rate_response.rb
|
|
383
|
+
- lib/pharmaobservatory/models/trial_enrollment_rate_row.rb
|
|
384
|
+
- lib/pharmaobservatory/models/trial_extracted_endpoints_response.rb
|
|
385
|
+
- lib/pharmaobservatory/models/trial_extracted_endpoints_row.rb
|
|
386
|
+
- lib/pharmaobservatory/models/trial_outcome_measures_response.rb
|
|
387
|
+
- lib/pharmaobservatory/models/trial_outcome_measures_row.rb
|
|
388
|
+
- lib/pharmaobservatory/models/trial_sites_response.rb
|
|
389
|
+
- lib/pharmaobservatory/models/trial_sites_row.rb
|
|
390
|
+
- lib/pharmaobservatory/models/trials_record.rb
|
|
391
|
+
- lib/pharmaobservatory/models/trials_record_attributes.rb
|
|
392
|
+
- lib/pharmaobservatory/models/trials_response.rb
|
|
393
|
+
- lib/pharmaobservatory/models/trials_row.rb
|
|
268
394
|
- lib/pharmaobservatory/version.rb
|
|
269
395
|
homepage: https://pharmaobservatory.com
|
|
270
396
|
licenses:
|